Diagnostics to support malaria elimination: Choosing an appropriate biomarker to target the subclinical Plasmodium falciparum transmission reservoir

Proceedings of the 4th IEEE Global Humanitarian Technology Conference, GHTC 2014

Volumn , Issue , 2014, Pages 561-568

  Hawkins, K ^a   Burton, R ^a   Labarre, P ^a  

^a PATH   (United States)

Author keywords

18S rRNA; AMA 1; antigen detection; HRP2; intrinsic property; LDH; limit of detection; molecular detection; MSP 1; parasite density; persistence; sensitivity; sequestration; serology; specificity

Indexed keywords

DISEASES; MALARIA CONTROL; PROGRAM DIAGNOSTICS; RNA; TRANSMISSIONS;

18S RRNA; AMA-1; ANTIGEN DETECTIONS; HRP2; INTRINSIC PROPERTY; LIMIT OF DETECTION; MOLECULAR DETECTION; MSP-1; PARASITE; PERSISTENCE; SENSITIVITY; SEQUESTRATION; SEROLOGY; SPECIFICITY;

BIOMARKERS;

EID: 84936762761     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/GHTC.2014.6970339     Document Type: Conference Paper

References (66)

1. World Health Organization (WHO), "World Malaria Report 2013," Geneva: WHO, 2013.
2. J. Bousema, L. C. Gouagna, C. J. Drakeley, A. M. Meutstege, B. A. Okech, I. N. Akim, et al, "Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya," Malar J, vol. 3, doi: 10.1186/1475-2875-3-18, June 2004.
3. I. Harris. W. W. Sharrock, L. M. Bain, K. A. Gray, A. Bobogare, L. Boaz, et al, "A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting," Malar J, vol. 9, doi: 10.1186/1475-2875-9-254, September 2010.
4. M. D. Young and N. F. Hardman, "The infectivity of native malarias in South Carolina to Anopheles quadrimaculatus," Am J Trop Med Hyg," vol. 28, pp. 303-311, March 1948.
5. F. P. Alves, L. H. Gil, M. T. Marrelli, P. E. Ribolla, E. P. Camargo, and L. H. Da Silva, "Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon," J Med Entomol, vol. 42, pp. 777-779, September 2005.
6. L. C. Okell, T. Bousema, J. T. Griffin, A. L. Ouédraogo, A. C. Ghani, and C. J. Drakeley, "Factors determining the occurrence of submicroscopic malaria infections and their relevance for control," Nat Commun, vol. 3, doi: 10.1038/ncomms2241, 2012.
7. WHO, "Global Malaria Control and Elimination: Report of a Technical Review," Geneva: WHO, 2008.
8. I. M. Bashir, N. Otsyula, G. Awinda, M. Spring, P. Schneider, and J. N. Waitumbi, "Comparison of LDH ELISA, qPCR and microscopy for the detection of Plasmodium events and prediction of sick visits during a malaria vaccine study," PLoS One, vol. 8, e56828, 2013.
9. The malERA Consultative Group on Monitoring, Evaluation, and Surveillance, "A research agenda for malaria eradication: diagnoses and diagnostics," PLoS Medicine, vol. 8, e1000396, 2011.
10. K. Tietje, K. Hawkins, C. Clerk, K. Ebels, S. McGray, C. Crudder, et al, "The essential role of infection-detection technologies for malaria elimination and eradication," Trends in Parasitology., vol. 30, pp. 259-266, May 2014.
11. J. N. Waitumbi, J. Gerlach, I. Afonina, S. B. Anyona, J. N. Koros, J. Siangla, et al, "Malaria prevalence defined by microscopy, antigen detection, DNA amplification and total nucleic acid amplification in a malaria-endemic region during the peak malaria transmission season.," Trop Med Int Health, vol. 16, pp. 786-793, July 2011.
12. G. M. Jeffrey and D. E. Eyles, "Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection," The American Journal of Tropical Medicine and Hygiene, vol. 4, pp. 781-789, September 1955.
13. V. Delley, P. Bouvier, N. Breslow, O. Doumbo, I. Sagara, M. Diakite, et al, "What does a single determination of malaria parasite density mean? A longitudinal survey in Mali," Tropical Medicine &International Health, vol. 5,pp. 404-412, June 2000.
14. W. P. O'Meara, F. E. McKenzie, A. J. Magill, J. R. Forney, B. Permpanich, C. Lucas, et al, "Sources of variability in determining malaria parasite density by microscopy," The American Journal of Tropical Medicine and Hygiene, vol. 73, pp. 593-598, September 2005.
15. A. Farnert. G. Snounou, I. Rooth, and A. Bjorkman, "Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area," The American Journal of Tropical Medicine and Hygiene, vol. 56, pp. 538-547, May 1997.
16. G. Di Perri, P. Olliaro, S. Nardi, B. Allegranzi, R. Deganello, S. Vento, et al, "The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria," Trans R Soc Trop Med Hyg, vol. 91, pp. 403-405, July 1997.
17. H. M. Kodisinghe, K. L. Perera, S. Premawansa, T. Naotunne, A. R. Wickramasinghe, and K. N. Mendis, "The ParaSight-F dipstick test as a routine diagnostic tool for malaria in Sri Lanka," Trans R Soc Trop Med Hyg, vol. 91, pp. 398-402, July 1997.
18. K. Silamut, N. H. Phu, C. Whitty, G. D. Turner, K. Louwrier, N. T. Mai, et al, "A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain," Am J Pathol, vol. 155, pp. 395-410, August 1999.
19. National Institute of Allergy and Infectious Diseases, "Life Cycle of the Malaria Parasite Stage," Available at: http://www.niaid.nih.gov/topics/malaria/pages/lifecycle.aspx, Accessed June 17, 2013.
20. Centers for Disease Control and Prevention, "Malaria Diagnostic Findings," Available at: http://www.dpd.cdc.gov/dpdx/HTML/Frames/MR/ Malaria/body-Malariadiagfind2.htm, Accessed June 17, 2013.
21. T. Bousema and C. Drakeley, "Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination," Clin Microbiol Rev, vol. 24, pp. 377-410, April 2011.
22. G. Snounou, "Detection and identification of the four malaria parasite species infecting humans by PCR amplification," Methods Mol Biol., vol. 50, 263-291, 1996.
23. N. Steenkeste, S. Incardona, S. Chy, L. Duval, M. T. Ekala, P. Lim, et al, "Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers," Malar J, vol. 8, doi: 10.1186/1475-2875-8-86, April 2009.
24. G. Snounou, S. Viriyakosol, X. P. Zhu, W. Jarra, L. Pinheiro, V. E. do Rosario, et al, "High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction," Mol Biochem Parasitol, vol 61, pp. 315-320, October 1993.
25. S. C. Murphy, J. L. Prentice, K. Williamson, C. K. Wallis, F. C. Fang, M. Fried, et al, "Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials," Am J Trop Med Hyg, vol. 86, pp. 383-394, March 2012.
26. A. H. Cooke, P. L. Chiodini, T. Doherty, A. H. Moody, J. Ries, and M. Pinder, "Comparison of a parasite lactate dehydrogenase-based immunochromatographic antigen detection assay (OptiMAL) with microscopy for the detection of malaria parasites in human blood samples," Am J Trop Med Hyg, vol. 60, pp. 173-176, February 1999.
27. J. Baker, J. McCarthy, M. Gatton, D. E. Kyle, V. Belizario, J. Luchavez, et al, "Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests," J Infect Dis, vol. 192, pp. 870-877, September 2005.
28. J. Baker, M. F. Ho, A. Pelecanos, M. Gatton, N. Chen, S. Abdullah, et al, "Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests," Malar J, vol. 9, doi: 10.1186/1475-2875-9-129, May 2010.
29. A. M. Dondorp, V. Desakorn, W. Pongtavornpinyo, D. Sahassananda, K. Silamut, K. Chotivanich, et al, "Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2," PLoS Med, vol. 2, e204, August 2005.
30. I. C. Hendriksen, L. J. White, J. Veenemans, G. Mtove, C. Woodrow, B. Amos, et al, "Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration," J Infect Dis, vol. 207, pp. 351-361, January 2013.
31. A. O. Fung, R. Damoiseaux, S. Grundeen, J. L. Panes, D. H. Horton, J. W. Judy, et al, "Quantitative detection of PfHRP2 in saliva of malaria patients in the Philippines," Malar J, vol. 11, doi: 10.1186/1475-2875-11-175, May 2012.
32. M. Mayxay, S. Pukrittayakamee, K. Chotivanich, S. Looareesuwan, and N. J. White, "Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria," Trans R Soc Trop Med Hyg, vol. 95, pp. 179-182, March 2001.
33. J. Cook, N. Speybroeck, T. Sochanta, H. Somony, M. Sokny, F. Claes, et al, "Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia," Malar J, vol. 11, doi: 10.1186/1475-2875-11-86, March 2012.
34. S. M. Kinyanjui, D. J. Conway, D. E. Lanar, and K. Marsh, "IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life," Malar J, vol. 6, June 2007.
35. J. Cook, H. Reid, J. Iavro, M. Kuwahata, G. Taleo, A. Clements, et al, "Using serological measures to monitor changes in malaria transmission in Vanuatu," Malar J. vol. 9, doi: 10.1186/1475-2875-9-169, June 2010.
36. T. Bousema, R. M. Youssef, J. Cook, J. Cox, V. A. Alegana, J. Amran, et al, "Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008," Emerg Infect Dis, vol. 16, pp. 392-399, March 2010.
37. F. Ibison, A. Olotu, D. M. Muema, J. Mwacharo, E. Ohuma, D. Kimani, et al, "Lack of avidity maturation of merozoite antigenspecific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed
38. G. Snounou, S. Viriyakosol, W. Jarra, S. Thaithong, and K. N. Brown, "Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections," Mol Biochem Parasitol, vol. 58, 283-292, April 1993.
39. C. G. Haanshuus, S. C. Mohn, K. Morch, N. Langeland, B. Blomberg, and K. Hanevik, "A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway," Malar J, vol. 12, doi: 10.1186/1475-2875-12-26, January 2013.
40. C. Farrugia, O. Cabaret, F. Botterel, C. Bories, F. Foulet, J. M. Costa, et al, "Cytochrome b gene quantitative PCR for diagnosing Plasmodium falciparum infection in travelers," J Clin Microbiol, vol. 49, pp. 2191-2195, June 2011.
41. S. D. Polley, Y. Mori, J. Watson, M. D. Perkins, I. J. González, T. Notomi, et al, "Mitochondrial DNA targets increase sensitivity of malaria detection using loop-mediated isothermal amplification," J Clin Microbiol, vol. 48, pp. 2866-2871, August 2010.
42. S. D. Polley, I. J. Gonzalez, D. Mohamed, R. Daly, K. Bowers, J. Watson, et al, "Clinical evaluation of a loop-mediated amplification test kit for Diagnosis of Imported Malaria," J Infect Dis, vol. 208, pp. 637-644, August 2013.
43. A. Demas, J. Oberstaller, J. DeBarry, N. W. Lucchi, G. Srinivasamoorthy, D. Sumari, et al, "Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S Rrna," J Clin Microbiol, vol. 49, pp. 2411-2418, July 2011.
44. P. Schneide, G. Schoone, H. Schallig, D. Verhage, D. Telgt, W. Eling, et al, "Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification," Mol and Biochem Parasitol, vol. 137, pp. 35-41, September 2004.
45. G. J. Schoone, L. Oskam, N. C. Kroon, H. D. Schallig, and S. A. Omar, "Detection and quantification of Plasmodium falciparum in blood samples using quantitative nucleic acid sequence-based amplification," J Clin Microbiol, vol. 38, pp. 4072-4075, November 2000.
46. H. Lemma, P. Byass, A. Desta, A. Bosman, G. Costanzo, L. Toma, et al, "Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources," Trop Med Int Health, vol. 15, pp. 241-250, February 2010.
47. A. B. Tiono, T. Konate, N. Convelbo, E. Convelbo, F. Pagnoni, and B. S. Sirima, "Role of rapid diagnostic testing (RDT) in the context of home management of childhood fever (HMCF) with dispersible artemether-lumefantrine: an open table randomized controlled trial in a rural and seasonal malaria transmission area of Burkina Faso," Presented at: ASTMH 59th Annual Meeting, November 3, 2010; Atlanta, GA.
48. K. Yeboah-Antwi, P. Pilingana, W. B. Macleod, K. Semrau, K. Siazeele, P. Kalesha, et al, "Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial," PLoS Med, vol. 7, e1000340, September 2010.
49. P. Chanda, B. Hamainza, H. B. Moonga, V. Chalwe, and F. Pagnoni, "Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers," Malar J, vol. 10, doi: 10.1186/1475-2875-10-158, June 2011.
50. L. Bissonnette and M. G. Bergeron, "Diagnosing infections-current and anticipated technologies for point-of-care diagnostics and homebased testing," Clin Microbiol Infect, vol. 16, pp. 1044-1053, August 2013.
51. V. D'Acremont, C. Lengeler, and B. Genton, "Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review," Malar J, vol. 9, doi: 10.1186/1475-2875-9-240, August 2010.
52. J. Yukich, V. D'Acremont, J. Kahama, N. Swai, and C. Lengeler, "Cost savings with rapid diagnostic tests for malaria in lowtransmission areas: evidence from Dar es Salaam, Tanzania," Am J Trop Med Hyg, vol. 83, pp. 61-68, July 2010.
53. T. Ramutton, I. C. Hendriksen, J. Mwanga-Amumpaire, G. Mtove, R. Olaosebikan, A. K. Tshefu, et al, "Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria," Malar J, vol. 11, doi: 10.1186/1475-2875-11-276, August 2012.
54. Rubach MP, Mukemba J, Florence S, John B, Crookston B, Lopansri BK, et al, "Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children," PLoS One, vol. 7, doi: 10.1371/journal.pone.0035985, May 2012.
55. S. Portugal, S. K. Pierce, and P. D. Crompton, "Young Lives Lost as B Cells Falter: What we are learning about antibody responses in malaria," J Immunol, vol. 190, pp. 3039-3046, April 2013.
56. M. U. Ferreira, N. M. da Silva, and G. Wunderlich, "Antigenic diversity and immune evasion by malaria parasites," Clin Diagn Lab Immunol, vol. 11, pp. 987-995, November 2004.
57. A. Scherf, J. J. Lopez-Rubio, and L. Riviere, "Antigenic variation in Plasmodium falciparum," Annu Rev Microbiol, vol. 62, pp. 445-470, 2008.
58. Deme AB, Park DJ, Bei AK, Sarr O, Badiane AS, Gueye Pel H, et al, "Analysis of pfhrp2 genetic diversity in Senegal and implications for use of rapid diagnostic tests," Malar J, vol. 13, doi: 10.1186/1475-2875-13-34, January 2014.
59. Baker J, Gatton ML, Peters J, Ho MF, McCarthy JS, Cheng Q, "Transcription and expression of Plasmodium falciparum histidinerich proteins in different stages and strains: implications for rapid diagnostic tests," PLoS One, vol. 6, doi: 10.1371/journal.pone.0022593, July 2011.
60. Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, et al, "Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum," Trans R Soc Trop Med Hyg, vol. 99, pp. 517-524, July 2005.
61. Noedl H, Wongsrichanalai C, Miller RS, Myint KS, Looareesuwan S, Sukthana Y, et al, "Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein II," Exp Parasitol, vol. 102, pp. 157-163, November-December 2002.
62. V. Udhayakumar and J. Barnwell, "Molecular Profile and Survey of HRP2 and HRP3 Genetic Deletions in South America," Presented at: AMI/RAVREDA Annual Meeting, April 9, 2013; Lima, Peru.
63. P. D. Crompton, M. A. Kayala, B. Traore, K. Kayentao, A. Ongoiba, G. E. Weiss, et al, "A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray," Proc Natl Acad Sci U S A, vol. 107, pp. 6958-6963, April 2010.
64. S. B. Reddy, R. F. Anders, J. G. Beeson, A. Färnert, F. Kironde, S. K. Berenzon, et al, "High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria," PLoS One, vol. 7, e32242, 2012.
65. F. M. Leoratti, R. R. Durlacher, M. V. Lacerda, M. G. Alecrim, A. W. Ferreira, M. C. Sanchez, et al, "Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria," Malar J, vol. 7, doi: 10.1186/1475-2875-7-186, September 2008.
66. O. Akpogheneta, S. Dunyo, M. Pinder, and D. Conway, "Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection," Parasite Immunol, vol. 32, pp. 296-304, April 2010.